Judge Rules FDA Can Regulate Stem Cell Treatment As Drug
A Washington federal judge on Monday threw out a suit against the U.S. Food and Drug Administration challenging its regulation of a stem cell treatment, finding the procedure constitutes a drug...To view the full article, register now.
Already a subscriber? Click here to view full article